The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Dec. 25, 2012

Filed:

Dec. 08, 2006
Applicants:

Joerg Bredno, San Francisco, CA (US);

Alexandra Groth, Aachen, DE;

Juergen Weese, Aachen, DE;

Antonius Johannes Cornelius Bruijns, Best, NL;

Peter Maria Johannes Rongen, Eindhoven, NL;

Ronaldus Petrus Johannes Hermans, Den Bosch, NL;

Heidrun Steinhauser, Eindhoven, NL;

Inventors:

Joerg Bredno, San Francisco, CA (US);

Alexandra Groth, Aachen, DE;

Juergen Weese, Aachen, DE;

Antonius Johannes Cornelius Bruijns, Best, NL;

Peter Maria Johannes Rongen, Eindhoven, NL;

Ronaldus Petrus Johannes Hermans, Den Bosch, NL;

Heidrun Steinhauser, Eindhoven, NL;

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61B 6/00 (2006.01); G06K 9/00 (2006.01); G06G 7/58 (2006.01);
U.S. Cl.
CPC ...
Abstract

A system, apparatus and method are provided for measuring and removing the influence of pulsatility on contrast agent flow in a region of interest of a vascular system of a patient. Once the change of blood speed over the cardiac cycle is known (pulsatility), this influence is removed from acquired image sequence for outcome control such that 'quasi-stationary', regular flow acquisition is passed on to subsequent visualization and analysis processes. A contrast agent injector is also provided that simultaneously measures and uses ECG to inject a known contrast agent at a fixed point over the cardiac cycle or such that a known amount of contrast agent will arrive at a known time at a region of interest in the vasculature of a patient, thus controlling one of the main unwanted variables in an acquisition of blood flow sequences.


Find Patent Forward Citations

Loading…